ImmuPharma France SA
7Patents
4Active
7Granted
38Portfolio score
Filing activity: Jun 13, 2001 → Dec 11, 2015 · 2 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7186739B2 | Stabilized activated derivatives of carbamic acid, their process of preparation and their use for the preparation of ureas | Chemistry; Metallurgy | 7 | Expired |
| US7186828B2 | Cyclic urea compounds and preparation thereof | Emerging Cross-Sectional Technologies | 7 | Expired |
| US7691807B2 | Hybrid oligomers, their preparation process and pharmaceutical compositions containing them | Chemistry; Metallurgy | 5 | Expired |
| US8138145B2 | Hybrid oligomers, their preparation process and pharmaceutical compositions containing them | Chemistry; Metallurgy | 4 | Active |
| US9657072B2 | Modified peptides and their use for treating autoimmune diseases | Human Necessities | 0 | Active |
| US7777030B2 | Compositions and methods for the treatment and prevention of disease | Emerging Cross-Sectional Technologies | 0 | Active |
| US10213482B2 | Methods of treating chronic inflammatory diseases | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.